BofA analyst Vivek Arya raised the firm’s price target on Synopsys (SNPS) to $575 from $560 and keeps a Buy rating on the shares. While Synopsys delivered “strong” Q2 results and FY25 guidance was “resilient,” China weakness is still a concern, the analyst tells investors. Despite being widely reported in the media prior to the quarterly report, Synopsys stated it has not received any notice from BIS regarding potential new export restrictions on EDA software to China, the analyst noted. Following the report, the firm tweaked up its FY25, FY26 and FY27 pro-forma EPS estimates by 1% each fiscal year.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys: Strong Performance and Resilience Amid Geopolitical Uncertainty
- Synopsys Positioned for Growth: AI and Hardware Innovations Drive Buy Rating
- Synopsys Buy Rating Affirmed Amid Strong Financial Performance and Growth Prospects Despite Geopolitical Risks
- Hold Rating for Synopsys Amid Geopolitical Risks and Market Stability Concerns
- Synopsys: Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Market Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue